ArticleOphthalmology and therapy2024

Efficacy, Safety and Immunogenicity of Sun's Ranibizumab Biosimilar in Neovascular Age-Related Macular Degeneration: A Phase 3, Double-Blind Comparative Study.

Asim K Ghosh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.